Literature DB >> 7223791

Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients.

D E Zaske, R J Cipolle, R G Strate, W F Dickes.   

Abstract

Wide interpatient variations were demonstrated in gentamicin elimination rate and dosage requirements for 249 gynecology patients with normal renal function. These variations combined with the need to obtain narrow ranges in serum levels necessitated measuring serum concentrations and individually calculating each patient's dose and dosing interval. Optimal peak and trough serum concentrations were reliably and rapidly achieved by means of this method. Required dosage regimens ranged from 1.9 to 14.0 mg/kg/day. Ototoxicity and nephrotoxicity did not occur in these patients. These results further emphasize the need to measure serum concentrations and make necessary dosage adjustments to ensure therapeutic levels. However, because of the wide interpatient variation, these increased dosages are not routinely suggested without previously measuring serum concentrations and calculating each patient's dosage regimen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7223791     DOI: 10.1016/0002-9378(81)90954-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Influence of age on tobramycin pharmacokinetics in patients with normal renal function.

Authors:  L A Bauer; R A Blouin
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

2.  Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.

Authors:  J V Etzel; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

3.  Fever and associated changes in glomerular filtration rate erase anticipated diurnal variations in aminoglycoside pharmacokinetics.

Authors:  F Fauvelle; P Perrin; L Belfayol; M Boukari; P Cherrier; A M Bosio; M Tod; J M Coulaud; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Gentamicin pharmacokinetics in patients with malignancies.

Authors:  J S Bertino; L A Booker; P Franck; B Rybicki
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

5.  Increased aminoglycoside dosage requirements in hematologic malignancy.

Authors:  R G Zeitany; N S El Saghir; C R Santhosh-Kumar; M A Sigmon
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Pharmacokinetics of antibiotics in critically ill patients.

Authors:  R van Dalen; T B Vree
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 7.  Comparison of drug dosing methods.

Authors:  M E Burton; M R Vasko; D C Brater
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

Review 8.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

9.  Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.

Authors:  S T Donta; L A Lembke
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.